Company Overview
- Headquarters
- 11711 N. Meridian Street, Suite 300, Carmel IN
- Website
- mbxbio.com
- Phone
- (317) 659-0200
- Employees
- 18
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$10B
Who is MBX Biosciences Inc
MBX Biosciences, Inc. is a clinical stage biopharmaceutical company based in Carmel, Indiana. The company employs 18 people and has generated over $10,000 in revenue. MBX Biosciences specializes in the development of Precision Endocrine Peptides (PEPs™), a novel therapeutic approach designed to improve upon traditional peptide treatments. Their PEP candidates aim to address the unmet medical needs of patients with endocrine disorders. The company's lead product candidate, MBX 2109, is currently undergoing a Phase 1 clinical trial for the treatment of hypoparathyroidism. The company's leadership team boasts extensive experience in the discovery, development, and commercialization of successful endocrine therapeutics, including Forteo® and Humalog®. MBX Biosciences is backed by prominent life science investors such as Frazier Life Sciences, New Enterprise Associates, and OrbiMed. For more information about MBX Biosciences and its innovative PEP technology, please visit their website at mbxbio.com.
Company Leadership
Companies Similar to MBX Biosciences Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to MBX Biosciences Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 18 | Arizona City, AZ | 1998 | |
| 10M | 9 | San Diego, CA | ||
| 10M | 6 | Campbell, CA | 2011 | |
| 10M | 2 | Torrington, WY | ||
| 10M | 1 | San Diego, CA | 2016 |